In triple-negative breast cancer (TNBC), overexpression of MIR4435-2HG promotes frizzled homolog 7 (FZD7) expression in cells, thereby activating the Wnt/β-catenin signaling pathway (37). Here, FZD7 is linked to triple-negative breast carcinoma.